DOCSLIB.ORG

Use of Terlipressin in Amitriptylin Overdose

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Use of Terlipressin in Amitriptylin Overdose Netherlands Journal of Critical Care Copyright © 2011, Nederlandse Vereniging voor Intensive Care. All Rights Reserved. Received July 2010; accepted September 2010 CASEREPORT Useofterlipressininamitriptylinoverdose DLJMoolenaar1,BMvanderOord2,AManten2 1 DepartmentofInternalMedicine,MeanderMedicalCentre,Amersfoort,TheNetherlands 2 DepartmentofIntensiveCare,MeanderMedicalCentre,Amersfoort,TheNetherlands Abstract- This case report describes a patient with severe hypotension due to amitriptyline intoxication not responding to volume suppletion, sodium bicarbonate administration and high dose vasopressive therapy. A very good response was elicited by administering 2 mg of terlipressin which resulted in a quick and uneventful recovery within a few hours. Keywords- Tricyclic poisoning, hypotension/chemically induced, terlipressin Introduction loading dose of 100 mmol (100 ml of 8.4% solution). Shortly after Amitriptyline is an important member of the group of tricyclic admission, the patient developed deep hypotension with warm antidepressants and has been used to treat depression since extremities and a central venous pressure of 10 mmHg. The the 1950s. Unfortunately, it is also a commonly used drug in hypotension was refractory to our volume expansion, additional intentional overdose. In a retrospective Dutch analysis, up to bicarbonate administration of 200 mmol (200 ml of 8.4% solution) 25% of intoxication-related ICU admissions were found to be due and high dose norepinephrine therapy (up to 1.5 microgram/ to tricyclic overdose, even though other antidepressant drugs kg/min), and eventually dropped to 60/30 mmHg. During this (mostly SSRIs) where prescribed more often [1]. deep hypotension, the patient had multiple severe generalized tonic-clonic seizures, for which we successfully administered Casereport clonazepam and midazolam. A 49-year old man was brought to the emergency department after having ingested 190 tablets of amitriptyline 75 mg and approximately 1 litre of whiskey. He had been found unconscious Table 1. Laboratory results. by the paramedics, alerted by his wife after she had received a text message from him. His medical history stated that he had been under psychiatric treatment since 2007 for major 1 2 3 4 5 6 7 depression. pH 7.31 7.39 7.11 7.23 7.52 7.59 7.56 On admission he was comatose with a Glasgow Coma Score pCO2 (kPa) 6.3 5.4 11.1 7.5 4.4 3.8 4.7 of E1M1V1. His blood pressure was within normal range, his Bicarbonate 23 24 26 23 27 26 31 pulse was rapid and regular, his breathing was deep and slow (mmol/l) and his body temperature was 35°C. The rest of his physical pO2 (kPa) 24.9 16.6 23 31.1 12.6 12 12.8 examination was unremarkable. Saturation 99% 98% 99% 99% 98% 98% 98% Initial laboratory results showed a respiratory acidosis, with Base excess -3 -1 -6 -5 4 6 9 preserved oxygenation (table 1). His ethanol level was 0.6‰. The Lactate 11.1 8.7 4.5 initial ECG showed an accelerated idioventricular rhythm at 130 (mmol/l) beats per minute, a prolonged QRS-interval of 162 milliseconds Amitriptyline 1350 and some repolarisation abnormalities (figure 1). (ug/L) The diagnosis of severe combined amitriptyline- and alcohol Nortriptyline 210 intoxication was made and the patient was admitted to our (ug/L) intensive care unit where he was intubated and mechanically 1. Hospital admission. ventilated. 2. After mechanical ventilation was started and treatment with sodium We initiated general supportive care and administered bicarbonate initiated. activated charcoal and sodium bicarbonate 12 mmol/hr after a 3. During seizure and deep hypotension, three hours after admission. 4. Directly after the seizure was terminated. Correspondence 5. An extra dose of 200 mmol (200ml of naHCo3 8,4%) was given in 30 min. A. Manten 6. Two hours later terlipressin was given. 7. Three hours later norepinephrine was almost discontinued E-mail: [email protected] 76 NETH J CRIT CARE - VOLUME 15 - NO 2 - APRIL 2011 Netherlands Journal of Critical Care Use of terlipressin in amitriptylin overdose An ECG was made immediately following the seizures and showed Tricyclic antidepressant drugs are highly lipid soluble and rapidly a widening of the QRS-complex resembling an almost sinusoid absorbed from the gastro-intestinal tract. Peak levels usually wave, and was classified as an accelerated idioventricular rhythm occur within 2 hours. Because of its high lipid-solubility, it is (figure 2). Amitriptyline- and nortriptyline levels were drawn widely distributed into tissues and therefore has a high volume shortly afterwards, and established as very high – amitriptyline of distribution. 1350 ug/L and nortriptyline 210 ug/L, which is more than three Most of the tricyclic antidepressants are highly protein-bound: times the lower limit of toxicity [2]. less than 10% is unbound to protein (mostly albumine) depending Terlipressin was administered intravenously in a dose of 2 mg, on the pH of plasma. In acidosis, the bound fraction decreases after which the blood pressure returned to almost normal levels whereas in alkalosis it increases. This is especially important with within minutes and required only slight amounts of norepinephrine amitriptyline, as a pH higher than 7.4 can increase the protein- to be maintained. No additional administration of terlipressin was bound fraction by more than 42% [2]. needed. Amitriptyline is metabolized to nortriptyline and 10-hydroxynor- The patient regained consciousness within 24 hours. He was triptyline by the hepatic cytochrome P-450 oxidative enzyme- extubated and on neurologic examination appeared to have system. This system saturates quickly in overdose, increasing suffered no permanent sequelae from this incident. He was the elimination half-life time by as much as 100% in some cases. discharged to the psychiatric ward the next day. His ECG on Because of the high protein-bound fraction, renal excretion is discharge is shown in figure 3. only 3% to 10% [2]. All tricyclics share their most potent pharmacological effect: Discussion a histamine-antagonism, which accounts for their sedative Amitriptyline is a tricyclic antidepressant and was approved as an properties, and reflect their origin; most if not all neuroleptics and anti-depressant in the USA in the 1950s, and shortly thereafter tricyclics were developed in the 1950s from antihistamines [4]. in the European Union and the Netherlands. Because of its The postsynaptic alpha-adrenergic receptor antagonist effect side-effects and lethality in overdose, it is no longer used as a is responsible for postural hypotension in therapeutic ranges and first-line drug when treating major depressive episodes, but has severe hypotension in overdose. From table 2, it may be deducted been replaced with serotonin reuptake inhibitors (SSRI), which that amitriptyline has the most potent affinity for theα -adrenergic are safer when taken in overdose [3]. However, it is still used receptor, as does its direct metabolite nortriptyline [5]. It also in the treatment of several other psychiatric disorders, such as blocks the GABA-a (gamma-aminobutyric acid) receptor, which obsessive-compulsive disorder, nocturnal enuresis, anxiety and may contribute to the development of seizures. By blocking the sleeping disorders. Furthermore, amitriptylin is used for the muscarine receptor, it has a potent anti-cholinergic effect, which treatment of neuropathic pains. can manifest as mildly as non-responsive wide pupils, or as Figure 1. ECG on presentation. Note the widened QRS-complex and the tachycardia, both hallmarks of severe amitriptylin intoxication. NETH J CRIT CARE - VOLUME 15 - NO 2 - APRIL 2011 77 Netherlands Journal of Critical Care DLJ Moolenaar, BM van der Oord, A Manten Tabel 2. Receptor profile, Ki (nmol/l), of TCAs and comparator drugs: severely as a full-blown anti-cholinergic syndrome with delirium, uptake inhibition and receptor antagonism (HCR data) urine retention, dry skin, tachycardia and paralytic ileus. Cardiac toxicity stems primarily from the blockade of sodium channels, thereby prolonging the QRS-complex and promoting DRuG REuptake POST-SYNAPTIC RECEPTOR arrhythmias. This association is so strong that a correlation exists INHIBITION antagonism between free TCA-drug concentration and QRS-prolongation, so that a wider QRS should be interpreted as an increased free TCA 5-HT NA H1 α1 Musc 5-HT2A concentration. A prolonged QT-interval is the result of blockade Mirtazapine* >10000 4600 0.14 500 670 16 of the potassium channels responsible for repolarisation, giving Mianserin* >4000 71 0.40 34 820 7 rise to dysrythmia generation (e.g. ventricular tachycardia). Doxepin 68 29.5 0.24 24 83 25 The most important therapeutic modalities in TCA poisoning Amitriptyline 20 50 1 27 18 29 are gastrointestinal adsorption via activated charcoal and the Imipramine 7 60 40 32 46 80 administration of sodium bicarbonate to promote the binding of Clomipramine 0.14 54 15 32 25 35 TCA to protein. Because it has such a high protein-bound fraction Nortriptyline 100 10 6.3 55 37 44 and volume of distribution, haemodialysis or haemofiltration are Dothiepin 78 70 4 400 38 260 not effective. Recently, several case reports have been published Desipramine* 18 0.83 110 100 100 280 documenting successful treatment with plasmapheresis [6,7]. Reboxetine* 58 7.2 310 >1000 >1000 >1000 Activated charcoal adsorbs tricyclic drugs, thereby preventing absorption and promoting removal. Its use is limited, however, Abbreviations: HCR, human cloned receptor. because of the quick absorption of TCAs from the gastro- smaller Ki values represent greater potency. note: where values are available from different laboratories and different experiments, affinities intestinal tract, decreasing usefulness 2-4 hours after ingestion. can vary by about one order of magnitude; mid-range values are given Also, several severe pulmonary complications have been repor- (table 2a and b gives ranges). ted, of which aspiration of stomach content or activated char coal Receptors: H1, Histamine type 1; musc, acetylcholine muscarinic; a” a, is the most important [8]. adrenoceptor. note that no HCR data are known for lofepramine.
Load more

Recommended publications
  • Muscarinic Acetylcholine Receptor
    mAChR Muscarinic acetylcholine receptor mAChRs (muscarinic acetylcholine receptors) are acetylcholine receptors that form G protein-receptor complexes in the cell membranes of certainneurons and other cells. They play several roles, including acting as the main end-receptor stimulated by acetylcholine released from postganglionic fibersin the parasympathetic nervous system. mAChRs are named as such because they are more sensitive to muscarine than to nicotine. Their counterparts are nicotinic acetylcholine receptors (nAChRs), receptor ion channels that are also important in the autonomic nervous system. Many drugs and other substances (for example pilocarpineand scopolamine) manipulate these two distinct receptors by acting as selective agonists or antagonists. Acetylcholine (ACh) is a neurotransmitter found extensively in the brain and the autonomic ganglia. www.MedChemExpress.com 1 mAChR Inhibitors & Modulators (+)-Cevimeline hydrochloride hemihydrate (-)-Cevimeline hydrochloride hemihydrate Cat. No.: HY-76772A Cat. No.: HY-76772B Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other… gastrointestinal, urinary, and reproductive systems and other… Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 1 mg, 5 mg 1 mg, 5 mg AC260584 Aclidinium Bromide Cat. No.: HY-100336 (LAS 34273; LAS-W 330) Cat.
    [Show full text]
  • Amanita Muscaria (Fly Agaric)
    J R Coll Physicians Edinb 2018; 48: 85–91 | doi: 10.4997/JRCPE.2018.119 PAPER Amanita muscaria (fly agaric): from a shamanistic hallucinogen to the search for acetylcholine HistoryMR Lee1, E Dukan2, I Milne3 & Humanities The mushroom Amanita muscaria (fly agaric) is widely distributed Correspondence to: throughout continental Europe and the UK. Its common name suggests MR Lee Abstract that it had been used to kill flies, until superseded by arsenic. The bioactive 112 Polwarth Terrace compounds occurring in the mushroom remained a mystery for long Merchiston periods of time, but eventually four hallucinogens were isolated from the Edinburgh EH11 1NN fungus: muscarine, muscimol, muscazone and ibotenic acid. UK The shamans of Eastern Siberia used the mushroom as an inebriant and a hallucinogen. In 1912, Henry Dale suggested that muscarine (or a closely related substance) was the transmitter at the parasympathetic nerve endings, where it would produce lacrimation, salivation, sweating, bronchoconstriction and increased intestinal motility. He and Otto Loewi eventually isolated the transmitter and showed that it was not muscarine but acetylcholine. The receptor is now known variously as cholinergic or muscarinic. From this basic knowledge, drugs such as pilocarpine (cholinergic) and ipratropium (anticholinergic) have been shown to be of value in glaucoma and diseases of the lungs, respectively. Keywords acetylcholine, atropine, choline, Dale, hyoscine, ipratropium, Loewi, muscarine, pilocarpine, physostigmine Declaration of interests No conflicts of interest declared Introduction recorded by the Swedish-American ethnologist Waldemar Jochelson, who lived with the tribes in the early part of the Amanita muscaria is probably the most easily recognised 20th century. His version of the tale reads as follows: mushroom in the British Isles with its scarlet cap spotted 1 with conical white fl eecy scales.
    [Show full text]
  • "GVS Assessment of Indacaterol/Glycopyrronium
    > Return address PO Box 320, 1110 AH Diemen National Health Care Institute Care II To the Minister of Medical Care and Sports Cardiovascular & Pulmonary PO Box 20350 Willem Dudokhof 1 2500 EJ Den Haag 1112 ZA Diemen PO Box 320 1110 AH Diemen www.zorginstituutnederland.nl [email protected] 2020037637 T +31 (0)20 797 85 55 Contact Dr T.H.L. Tran T +31 (0)6-12001412 Date 24 September 2020 Subject Enerzair® Breezhaler® (indacaterol/glycopyrronium/mometasone) Our reference 2020037637 Dear Ms van Ark, In your letter of 7 September 2020 (CIBG-20-0910), you asked Zorginstituut Nederland to assess whether the product indacaterol acetate/glycopyrronium/mometasone furoate (Enerzair® Breezhaler®) can be included in the Medicine Reimbursement System (GVS). Enerzair® Breezhaler® is a combination preparation with three active ingredients: indacaterol as acetate, a long-acting beta2-adrenergic agonist; glycopyrronium bromide, a long-acting muscarine receptor agonist; and mometasone furoate, a synthetic corticosteroid. Enerzair® Breezhaler® is registered for as a maintenance treatment of asthma in adult patients not adequately controlledwith a maintenance combination of a long- acting beta2-agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year. The dosage of Enerzair® Breezhaler® is one inhalation capsule to be inhaled once daily. The dosage in the capsules contains 150 micrograms of indacaterol (as acetate), combined with 63 micrograms of glycopyrronium bromide, which corresponds to 50 micrograms of glycopyrronium and 160 micrograms of mometasone furoate. Each dose delivered contains 114 micrograms of indacaterol, 58 micrograms of glycopyrronium bromide, which corresponds to 46 micrograms of glycopyrronium and 136 micrograms of mometasone furoate.
    [Show full text]
  • DE H 3670 001 PAR.Pdf
    Decentralised Procedure Public Assessment Report IPRABRONCH 250 Mikrogramm/ml Lösung für einen Vernebler Ipratropium bromide DE/H/3670/001/DC (former UK/H/3401/001/DC) Applicant: Institut Dr. Zoeller This module reflects the scientific discussion for the approval of IPRABRONCH 250 Mikrogramm/ml Lösung für einen Vernebler. The procedure was finalised at 10.03.2011. TABLE OF CONTENTS I. INTRODUCTION ......................................................................................................... 4 II. SCIENTIFIC OVERVIEW AND DISCUSSION ........................................................... 4 II.1 Quality aspects .............................................................................................................. 4 II.2 Non-clinical aspects ....................................................................................................... 5 II.3 Clinical aspects .............................................................................................................. 6 III. OVERALL CONCLUSION AND BENEFIT/RISK ASSESSMENT ............................. 6 ADMINISTRATIVE INFORMATION Proposed name of the medicinal IPRABRONCH 250 Mikrogramm/ml Lösung für einen product in the RMS Vernebler Name of the drug substance (INN Ipratropium bromide name): Pharmaco-therapeutic group R03BB01 (ATC Code): Pharmaceutical form(s) and Nebuliser Solution; 250 Micrograms per ml strength(s): Reference Number(s) for the DE/H/3670/001/DC (former UK/H/3401/001/DC) Decentralised Procedure Reference Member State: DE (former UK) Concerned
    [Show full text]
  • Drug and Medication Classification Schedule
    KENTUCKY HORSE RACING COMMISSION UNIFORM DRUG, MEDICATION, AND SUBSTANCE CLASSIFICATION SCHEDULE KHRC 8-020-1 (11/2018) Class A drugs, medications, and substances are those (1) that have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration, or (2) that lack approval by the United States Food and Drug Administration but have pharmacologic effects similar to certain Class B drugs, medications, or substances that are approved by the United States Food and Drug Administration. Acecarbromal Bolasterone Cimaterol Divalproex Fluanisone Acetophenazine Boldione Citalopram Dixyrazine Fludiazepam Adinazolam Brimondine Cllibucaine Donepezil Flunitrazepam Alcuronium Bromazepam Clobazam Dopamine Fluopromazine Alfentanil Bromfenac Clocapramine Doxacurium Fluoresone Almotriptan Bromisovalum Clomethiazole Doxapram Fluoxetine Alphaprodine Bromocriptine Clomipramine Doxazosin Flupenthixol Alpidem Bromperidol Clonazepam Doxefazepam Flupirtine Alprazolam Brotizolam Clorazepate Doxepin Flurazepam Alprenolol Bufexamac Clormecaine Droperidol Fluspirilene Althesin Bupivacaine Clostebol Duloxetine Flutoprazepam Aminorex Buprenorphine Clothiapine Eletriptan Fluvoxamine Amisulpride Buspirone Clotiazepam Enalapril Formebolone Amitriptyline Bupropion Cloxazolam Enciprazine Fosinopril Amobarbital Butabartital Clozapine Endorphins Furzabol Amoxapine Butacaine Cobratoxin Enkephalins Galantamine Amperozide Butalbital Cocaine Ephedrine Gallamine Amphetamine Butanilicaine Codeine
    [Show full text]
  • Muscarine Hyperpolarizes a Subpopulation of Neurons by Activating an M, Muscarinic Receptor in Rat Nucleus Raphe Magnus in Vitro
    The Journal of Neuroscience, March 1994, 74(3): 1332-l 338 Muscarine Hyperpolarizes a Subpopulation of Neurons by Activating an M, Muscarinic Receptor in Rat Nucleus Raphe Magnus in vitro 2. Z. Pan and J. T. Williams Vellum Institute, Oregon Health Sciences University, Portland, Oregon 97201 It has been shown previously that the muscarinic cholinergic ical studies (Bowker et al., 1983; Jones et al., 1986; Sherriff et system in the nucleus raphe magnus (NRM) is involved in al., 1991). The NRM receives cholinergic afferents originating the modulation of nociception. In this study, we examined from the cells in the pedunculopontine tegmental nucleus (Rye the direct actions of muscarine on the NRM neurons in a et al., 1988). Behavioral studies have shown that local appli- slice preparation. Muscarine (I-30 PM) produced a dose- cations of both muscarinic receptor agonists and antagonists dependent hyperpolarization in a subpopulation of the NRM into the NRM causeantinociception (Brodie and Proudfit, 1986; cells that contain 5-hydroxytryptamine (5-HT). In voltage Iwamoto, 1991). In previous in vivo studies, iontophoretic ap- clamp, the muscarine-induced outward current reversed po- plication of ACh has been reported to induce an inhibition or larity at the potassium equilibrium potential and was char- excitation in the spontaneousactivity of different groups of the acterized by strong inward rectification. The reversal poten- NRM cells (Behbehani, 1982; Wessendorfand Anderson, 1983; tial was dependent on external potassium concentration, Willcockson et al., 1983; Hentall et al., 1993). Neither the cel- suggesting that the hyperpolarization induced by muscarine lular mechanismunderlying the actionsof thesecholinergic agents was mediated through an increase in an inwardly rectifying on NRM neurons nor the muscarinic receptor subtypes that potassium conductance.
    [Show full text]
  • Psychopharmacology Handout
    5/17/2017 Psychopharmacology Robert M. Millay RN, MSN Ed Psychiatric Technician Programs Napa Valley College Important Neurotransmitters • Acetylcholine • Dopamine • GABA (gamma-aminobutyric acid) • Glutamate • Norepinephrine • Serotonin Acetylcholine Receptors: • Nicotine • Muscarine – Memory – Anticholinergic side effects 1 5/17/2017 Dopamine Receptors: • Nigrostriatal: Movement • Mesolimbic: Pleasure, delusions/hallucinations • Mesocortical: Mediates positive and negative symptoms, cognitive side effects • Tuberoinfundibular: Prolactin release Glutamate –v‐GABA • Excitatory neurotransmitter Serotonin & Norepinephrine • Inhibitory catecholamine • Mediates: – Cognitive effects – Emotions, including panic – Memory and anxiety – Violence and aggression – Sexual function – Sleep‐wake cycles 2 5/17/2017 Drug‐Related Variables • Mode/mechanism of action • Dosage form • Bioavailability • Onset, peak, duration of action • Serum, half‐life • Elimination method • Side effects/toxicities • Cost Client‐Related Variables • Diagnosis • Other disease states • Age • Weight • Anticholinergic susceptibility • History of side effects • Previous response • Compliance • Financial/insurance • Support system Antipsychotics Typical • Block D2 receptors • Differ in potency and side effects Atypical • Differ in mode of action, side effect, potency • Fewer… • Greater efficacy with negative symptoms… • Lower potential to increase… 3 5/17/2017 Symptom Dimensions of Psychosis Positive symptoms related to overactive dopamine neurons in mesolimbic pathway • Examples:
    [Show full text]
  • The Anti-Addiction Drug Ibogaine and the Heart: a Delicate Relation
    Molecules 2015, 20, 2208-2228; doi:10.3390/molecules20022208 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation Xaver Koenig * and Karlheinz Hilber * Department of Neurophysiology and Neuropharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, Vienna 1090, Austria * Authors to whom correspondence should be addressed; E-Mails: [email protected] (X.K.); [email protected] (K.H.); Tel.: +43-1-40160-31232 (X.K.); +43-1-40160-31230 (K.H.); Fax: +43-1-40160-931300 (X.K. & K.H.). Academic Editor: Patricia Valentao Received: 24 October 2014 / Accepted: 26 November 2014 / Published: 29 January 2015 Abstract: The plant indole alkaloid ibogaine has shown promising anti-addictive properties in animal studies. Ibogaine is also anti-addictive in humans as the drug alleviates drug craving and impedes relapse of drug use. Although not licensed as therapeutic drug and despite safety concerns, ibogaine is currently used as an anti-addiction medication in alternative medicine in dozens of clinics worldwide. In recent years, alarming reports of life-threatening complications and sudden death cases, temporally associated with the administration of ibogaine, have been accumulating. These adverse reactions were hypothesised to be associated with ibogaine’s propensity to induce cardiac arrhythmias. The aim of this review is to recapitulate the current knowledge about ibogaine’s effects on the heart and the cardiovascular system, and to assess the cardiac risks associated with the use of this drug in anti- addiction therapy. The actions of 18-methoxycoronaridine (18-MC), a less toxic ibogaine congener with anti-addictive properties, are also considered.
    [Show full text]
  • Inflammation Inhibits Muscarinic Signaling in in Vivo Canine Colonic
    0031-3998/02/5205-0756 PEDIATRIC RESEARCH Vol. 52, No. 5, 2002 Copyright © 2002 International Pediatric Research Foundation, Inc. Printed in U.S.A. Inflammation Inhibits Muscarinic Signaling in In Vivo Canine Colonic Circular Smooth Muscle Cells SUDARSHAN RAO JADCHERLA Sections of Neonatology, Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A. ABSTRACT We investigated the effects of experimental colitis on the seen in normal and inflamed states, suggesting the importance of muscarinic signaling properties and contractile behavior of ca- M2 receptor. These findings suggest that changes in muscarinic nine colonic circular smooth muscle. The hypotheses that inflam- response during colitis may contribute to the abnormal motility mation 1) inhibits in vivo muscarinic receptor mediated contrac- seen with inflammatory bowel disease. (Pediatr Res 52: 756– tions, and 2) alters receptor density or receptor-binding affinities 762, 2002) were tested. Muscarine was infused close-intra-arterially in seven conscious dogs during normal and experimental colitis states. Abbreviations Colonic circular muscle contractions were recorded via surgi- Ach, acetylcholine cally attached strain gauge transducers. Muscarine stimulated AUC, area under contractions phasic contractions in a dose-dependent manner, whereas colitis 4-DAMP, 4-diphenyl acetoxy-N-methyl-piperidine methiodide was inhibited. The inhibitory concentration 50% dose of M3 Methoctramine, N, N',-bis[6[[(2-methoxyphenyl) receptor inhibitor was several times lower than that of M1,M2, methyl]amino]hexyl]-1,8-octanediamine tetrahydrochloride and M4 inhibitors during normal and colitis. However, inflam- TTX, tetrodotoxin mation induced a significant leftward shift in the circular muscle IP3, inositol (1, 4, 5,)-triphosphate inhibitory dose-response curve of M2 inhibitor.
    [Show full text]
  • When Good Times Go Bad: Managing 'Legal High' Complications in The
    Journal name: Open Access Emergency Medicine Article Designation: REVIEW Year: 2018 Volume: 10 Open Access Emergency Medicine Dovepress Running head verso: Caffrey and Lank Running head recto: Legal highs open access to scientific and medical research DOI: http://dx.doi.org/10.2147/OAEM.S120120 Open Access Full Text Article REVIEW When good times go bad: managing ‘legal high’ complications in the emergency department Charles R Caffrey Abstract: Patients can use numerous drugs that exist outside of existing regulatory statutes in Patrick M Lank order to get “legal highs.” Legal psychoactive substances represent a challenge to the emergency medicine physician due to the sheer number of available agents, their multiple toxidromes and Department of Emergency Medicine, Feinberg School of Medicine, presentations, their escaping traditional methods of analysis, and the reluctance of patients to Northwestern University, Chicago, divulge their use of these agents. This paper endeavors to cover a wide variety of “legal highs,” IL, USA or uncontrolled psychoactive substances that may have abuse potential and may result in seri- ous toxicity. These agents include not only some novel psychoactive substances aka “designer drugs,” but also a wide variety of over-the-counter medications, herbal supplements, and even a household culinary spice. The care of patients in the emergency department who have used “legal high” substances is challenging. Patients may misunderstand the substance they have been exposed to, there are rarely any readily available laboratory confirmatory tests for these substances, and the exact substances being abused may change on a near-daily basis. This review will attempt to group legal agents into expected toxidromes and discuss associated common clinical manifestations and management.
    [Show full text]
  • Muscarine-Sensitive Acetylcholine Receptors in Guinea-Pig Atrial Pacemaker Cells at 290C and in Ileum at 290C and 370C R.B
    Br. J. Pharmac. (1976), 58, 613-620 A COMPARISON OF AFFINITY CONSTANTS FOR MUSCARINE-SENSITIVE ACETYLCHOLINE RECEPTORS IN GUINEA-PIG ATRIAL PACEMAKER CELLS AT 290C AND IN ILEUM AT 290C AND 370C R.B. BARLOW, K.J. BERRY, P.A.M. GLENTON, N.M. NIKOLAOU & K.S. SOH Departments of Pharmacology, Universities of Edinburgh and Bristol 1 The affinity of 17 compounds for muscarine-sensitive acetylcholine receptors in atrial pacemaker cells and ileum of the guinea-pig has been measured at 290C in Ringer-Locke solution. Measurements were also made at 370C with 7 of them. 2 Some of the compounds had much higher affinity for the receptors in the ileum than for those in the atria. For the most selective compound, 4-diphenylacetoxy-N-methylpiperidine methiodide, the difference was approximately 20-fold. The receptors in the atria are therefore different in structure from those in the ileum. 3 The effects of temperature on affinity are not the same for all the compounds tested, indicating different enthalpies and entropies of adsorption and accounting for some of the difficulty experienced in predicting the affinity ofnew compounds. Introduction From measurements of the affinity constants of a were three reasons for choosing this preparation. First, number of compounds for muscarine-sensitive because the agonist causes hyperpolarization in this acetylcholine receptors in the ileum, bronchial muscle tissue, compared with depolarization in the other pre- and iris of the guinea-pig, Barlow, Franks & Pearson parations. Second, because of the discovery that there (1972) concluded that the receptors were in- are differences among types of histamine receptor and distinguishable.
    [Show full text]
  • Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model?
    brain sciences Review Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model? Roberto Keller 1 , Tatiana Costa 1, Daniele Imperiale 2, Annamaria Bianco 3 , Elisa Rondini 3, Angela Hassiotis 4 and Marco O. Bertelli 3,* 1 Adult Autism Centre, Mental Health Department, ASL Città di Torino, 10138 Turin, Italy; [email protected] (R.K.); [email protected] (T.C.) 2 Neurology Unit, Maria Vittoria Hospital, ASL Città di Torino, 10144 Turin, Italy; [email protected] 3 CREA (Research and Clinical Centre), San Sebastiano Foundation, Misericordia di Firenze, 50142 Florence, Italy; [email protected] (A.B.); [email protected] (E.R.) 4 Division of Psychiatry, University College London, London W1T 7NF, UK; [email protected] * Correspondence: [email protected]; Tel.: +39-055-708880 Abstract: Background: Stereotypic behaviour can be defined as a clear behavioural pattern where a specific function or target cannot be identified, although it delays on time. Nonetheless, repetitive and stereotypical behaviours play a key role in both animal and human behaviour. Similar behaviours are observed across species, in typical human developmental phases, and in some neuropsychiatric conditions, such as Autism Spectrum Disorder (ASD) and Intellectual Disability. This evidence led to the spread of animal models of repetitive behaviours to better understand the neurobiological mechanisms underlying these dysfunctional behaviours and to gain better insight into their role and Citation: Keller, R.; Costa, T.; origin within ASD and other disorders. This, in turn, could lead to new treatments of those disorders Imperiale, D.; Bianco, A.; Rondini, E.; in humans. Method: This paper maps the literature on repetitive behaviours in animal models of ASD, Hassiotis, A.; Bertelli, M.O.
    [Show full text]